These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12965899)
1. Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected]. Colomar M; Puga I; López M; Massot M; Jorquera JI; Reina M; Vilaró S; Espel E Clin Diagn Lab Immunol; 2003 Sep; 10(5):751-6. PubMed ID: 12965899 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets. Khyatti M; Stefanescu I; Blagdon M; Menezes J J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983 [TBL] [Abstract][Full Text] [Related]
6. Development of a robust, higher throughput green fluorescent protein (GFP)-based Epstein-Barr Virus (EBV) micro-neutralization assay. Lin R; Heeke D; Liu H; Rao E; Marshall JD; Chio V; Cataniag F; Yu L; Zuo F; McCarthy MP J Virol Methods; 2017 Sep; 247():15-21. PubMed ID: 28457783 [TBL] [Abstract][Full Text] [Related]
7. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645 [TBL] [Abstract][Full Text] [Related]
8. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals. Aya T; Mizuno F; Osato T J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949 [TBL] [Abstract][Full Text] [Related]
9. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line. Ehrnst AC J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells. Patel PC; Menezes J Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292 [TBL] [Abstract][Full Text] [Related]
11. Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay. Sashihara J; Burbelo PD; Savoldo B; Pierson TC; Cohen JI Virology; 2009 Sep; 391(2):249-56. PubMed ID: 19584018 [TBL] [Abstract][Full Text] [Related]
12. [Real time observation of binding of measles virus to Vero cells and neutralization of measles virus by human immunoglobulin using optical biosensor--a new real time diagnosis system for viral infections]. Inoue K; Arai T Kansenshogaku Zasshi; 1998 Mar; 72(3):273-8. PubMed ID: 9585701 [TBL] [Abstract][Full Text] [Related]
13. Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers. Linde A; Fridell E; Dahl H; Andersson J; Biberfeld P; Wahren B J Clin Microbiol; 1990 Feb; 28(2):211-5. PubMed ID: 2155915 [TBL] [Abstract][Full Text] [Related]
14. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. Otto C; Hofmann J; Ruprecht K Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157 [TBL] [Abstract][Full Text] [Related]
16. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G; Dewey F; Klein G; Henle G; Henle W J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [TBL] [Abstract][Full Text] [Related]
17. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults. Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and enhanced antibody-dependent cell-mediated cytotoxicity using virally-infected target cells. Bosse D; Ades EW J Clin Lab Immunol; 1989 Jul; 29(3):109-10. PubMed ID: 2561291 [TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480 [TBL] [Abstract][Full Text] [Related]
20. A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. Corrales-Aguilar E; Trilling M; Reinhard H; Mercé-Maldonado E; Widera M; Schaal H; Zimmermann A; Mandelboim O; Hengel H J Immunol Methods; 2013 Jan; 387(1-2):21-35. PubMed ID: 23023090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]